Literature DB >> 19489879

Prevalence of chronic migraine and medication overuse headache in Germany--the German DMKG headache study.

A Straube1, V Pfaffenrath, K-H Ladwig, C Meisinger, W Hoffmann, K Fendrich, M Vennemann, K Berger.   

Abstract

Population-based epidemiological studies about the prevalence of chronic migraine using the 2004 International Headache Society (IHS) classification definition are rare. We analysed the data of the Deutsche Migräne und Kopfschmerz Gesellschaft headache study, which included 7417 adults in three regions of Germany, with respect to their headache. Additionally, body mass index, alcohol consumption and smoking behaviour were recorded. Using the IHS definition from 2004, chronic migraine was diagnosed in 0.2% of the population. Half of these patients also fulfilled the criteria of medication overuse headache (MOH). The distribution of migraine attacks per subject was highly skewed, with only 14% of all migraine patients having more than six migraine attacks per month. Patients with chronic migraine or MOH seem more often to be active smokers than controls without headache. A body mass index of ≥ 30 was present significantly more often in patients with MOH than in controls or in patients with episodic migraine. The skewed distribution of the numbers of attacks per patient supports the recommendation to differentiate between episodic migraine with low and high attack frequency, as is done in the classification of tension-type headache. It further suggests that migraine with high attack frequency might be biologically different. The higher prevalence of smokers and of patients with a body mass index ≥ 30 in chronic migraine or MOH supports the idea of a frontal dysfunction in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19489879     DOI: 10.1111/j.1468-2982.2009.01906.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  37 in total

Review 1.  Controversy over the classification of medication-overuse headache.

Authors:  Maurice B Vincent
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  Headache disorders: differentiating and managing the common subtypes.

Authors:  Fayyaz Ahmed
Journal:  Br J Pain       Date:  2012-08

Review 3.  Medication-overuse headache: a perspective review.

Authors:  Maria Lurenda Westergaard; Signe Bruun Munksgaard; Lars Bendtsen; Rigmor Højland Jensen
Journal:  Ther Adv Drug Saf       Date:  2016-06-30

Review 4.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

5.  [Headache therapy - pain therapy: common features and differences].

Authors:  S Förderreuther; A Straube
Journal:  Schmerz       Date:  2014-04       Impact factor: 1.107

Review 6.  Headache in Resource-Limited Settings.

Authors:  Yohannes W Woldeamanuel
Journal:  Curr Pain Headache Rep       Date:  2017-11-16

Review 7.  [Diagnosis and therapy of chronic headaches].

Authors:  A May; T P Jürgens
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

8.  Longitudinal assessment of gray matter volumes and white matter integrity in patients with medication-overuse headache.

Authors:  Yesim Beckmann; Sevgin Gökçe; Nabi Zorlu; H Sabiha Türe; Fazıl Gelal
Journal:  Neuroradiol J       Date:  2018-01-31

Review 9.  [Headache. Current status of research and treatment].

Authors:  A Straube; C Gaul
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

Review 10.  Chronic Headache Due to Overuse of Analgesics and Anti-Migraine Agents.

Authors:  Hans-Christoph Diener; Dagny Holle; Thomas Dresler; Charly Gaul
Journal:  Dtsch Arztebl Int       Date:  2018-06-01       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.